Renascience Inc. (TYO:4889)
Japan
· Delayed Price · Currency is JPY 1,817.00
-129.00 (-6.63%)
Jun 27, 2025, 3:30 PM JST
Renascience Revenue
In the fiscal year ending March 31, 2025, Renascience had annual revenue of 132.00M JPY, down -31.96%. Renascience had revenue of 67.00M in the quarter ending March 31, 2025, a decrease of -9.46%.
Revenue
132.00M
Revenue Growth
-31.96%
P/S Ratio
220.63
Revenue / Employee
n/a
Employees
4
Market Cap
29.12B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |